The score is held back primarily by weak financial performance—ongoing losses and a sharp 2025 (annual) profitability and operating cash flow setback. Technicals are supportive with price above major moving averages and moderate momentum, but valuation is constrained by negative earnings and no dividend support.
Positive Factors
Improved leverage
Material debt reduction to zero by 2025 meaningfully lowers refinancing and interest risk. A lighter leverage profile gives the company more runway to pursue product development, service expansion and integration projects, and reduces near-term liquidity pressure amid continuing losses.
Multi‑year revenue growth
Sustained top-line growth over multiple years shows persistent market demand for its inspection systems. Durable hardware sales plus after‑sales service and integration projects create a basis for recurring revenues that can scale fixed-cost absorption and improve margin potential over the medium term.
Specialized NDT technology
Proprietary laser-based inspection tech targets regulated food and pharma processes where quality controls are mission-critical. This specialization creates technical barriers, higher switching costs and aftermarket service opportunities, supporting durable competitive positioning and pricing power in niche end markets.
Negative Factors
Persistent losses
Chronic unprofitability erodes equity and constrains strategic flexibility. Persistent negative EBIT means the business has yet to demonstrate sustainable margins, forcing reliance on external capital or cost restructuring to reach self-sufficiency and limiting long-term return prospects for shareholders.
Inconsistent cash generation
Volatile and historically negative free cash flow indicates the business is not consistently self-funding. Irregular operating cash undermines ability to invest in R&D, maintain service levels, and absorb shocks without raising external capital, increasing dilution and financing risk over the medium term.
2025 profitability shock
A pronounced operating deterioration in 2025 signals margin vulnerability from cost inflation, adverse mix or one-offs. Such a shock reduces visibility into sustainable profitability, raises questions about unit economics and scalability, and implies management must fix structural issues to restore durable earnings.
Gasporox AB (GPX) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr74.64M
Dividend YieldN/A
Average Volume (3M)5.49K
Price to Earnings (P/E)―
Beta (1Y)-0.24
Revenue Growth-15.54%
EPS Growth-263.54%
CountrySE
Employees20
SectorGeneral
Sector StrengthN/A
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.11
Shares Outstanding9,353,246
10 Day Avg. Volume3,959
30 Day Avg. Volume5,488
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)3.52
Price to Sales (P/S)2.22
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.6
Revenue Forecast (FY)kr61.40M
Gasporox AB Business Overview & Revenue Model
Company DescriptionGasporox AB (publ) develops and commercializes products based on laser spectroscopy. It offers GasSpect series of sensors for headspace analysis; LeakSpect series of sensors for detecting leaks of carbon dioxide from packages; MicroLab laboratory instruments for research and development of packages and materials; and GPX1500, a non-intrusive oxygen headspace gas analyzer. The company also provides measurement services for package and process evaluations. Gasporox AB (publ) was founded in 2005 and is based in Lund, Sweden.
How the Company Makes MoneyGasporox makes money mainly by selling measurement and inspection systems used in industrial quality assurance and process control. Key revenue streams include (1) product revenue from the sale of hardware systems (e.g., in-line/at-line inspection equipment for package leak detection and related gas-measurement instruments), (2) recurring and ancillary revenue tied to those installations such as service, maintenance, calibration, spare parts, and customer support, and (3) project/application work where systems are adapted or integrated into customer production lines (typically involving engineering, installation, and validation activities). If the company has material revenue from software subscriptions, licensing, or specific named partnerships, that information is null because it is not available from the provided context.
Gasporox AB Financial Statement Overview
Summary
Strong multi-year revenue growth is outweighed by persistent net losses and consistently negative EBIT. The 2025 (annual) deterioration—deeply negative gross profit/EBIT and negative operating cash flow—raises near-term sustainability risk despite improved leverage.
Income Statement
34
Negative
Revenue has grown strongly over the multi-year period (from 2020 to 2024), and 2024 showed continued growth. However, profitability remains weak: net income is negative every year shown, and EBIT is also consistently negative. A key concern is the sharp deterioration in 2025 (annual) where gross profit and EBIT turned deeply negative versus prior years, suggesting either cost pressure, mix issues, or one-offs that materially hurt operating performance.
Balance Sheet
58
Neutral
Leverage looks manageable and has improved: total debt fell from 8.7M (2023) to 2.3M (2024) and is reported at 0 in 2025 (annual). Equity remains positive, providing a cushion. That said, equity has declined from 2024 to 2025 (annual), consistent with ongoing losses, and returns on equity are negative where provided—highlighting that the balance sheet strength is being eroded by lack of profitability.
Cash Flow
41
Neutral
Cash generation is inconsistent. Operating cash flow was positive in 2023 and 2024, but turned negative again in 2025 (annual), which raises near-term funding risk if losses persist. Free cash flow is negative in multiple years (2021–2024), indicating the business has not been self-funding, and the 2025 free cash flow figure is reported as 0 alongside a -100% growth rate, which signals volatility and/or reporting noise rather than a clear, durable improvement.
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
31.57M
34.10M
31.43M
21.45M
15.74M
Gross Profit
-7.98M
33.10M
30.69M
22.45M
16.26M
EBITDA
-1.55M
-347.00K
946.00K
-3.25M
-4.69M
Net Income
-7.71M
-2.68M
-1.25M
-4.56M
-5.39M
Balance Sheet
Total Assets
50.62M
39.97M
43.52M
44.43M
37.37M
Cash, Cash Equivalents and Short-Term Investments
6.65M
6.81M
10.62M
14.56M
14.27M
Total Debt
0.00
2.32M
8.73M
8.43M
0.00
Total Liabilities
30.76M
13.28M
20.33M
19.99M
8.74M
Stockholders Equity
19.86M
26.69M
23.19M
24.44M
28.63M
Cash Flow
Free Cash Flow
0.00
-3.52M
-3.98M
-8.28M
-9.91M
Operating Cash Flow
-4.72M
4.36M
3.34M
-1.19M
-3.39M
Investing Cash Flow
-7.65M
-7.52M
-7.04M
-7.01M
-6.52M
Financing Cash Flow
12.21M
-648.00K
-240.00K
8.50M
-53.00K
Gasporox AB Technical Analysis
Technical Analysis Sentiment
Positive
Last Price7.40
Price Trends
50DMA
7.05
Positive
100DMA
7.11
Positive
200DMA
7.30
Positive
Market Momentum
MACD
0.20
Negative
RSI
60.25
Neutral
STOCH
48.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GPX, the sentiment is Positive. The current price of 7.4 is above the 20-day moving average (MA) of 7.14, above the 50-day MA of 7.05, and above the 200-day MA of 7.30, indicating a bullish trend. The MACD of 0.20 indicates Negative momentum. The RSI at 60.25 is Neutral, neither overbought nor oversold. The STOCH value of 48.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:GPX.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026